Your browser doesn't support javascript.
loading
Pathogenic variants in CDH11 impair cell adhesion and cause Teebi hypertelorism syndrome.
Li, Dong; March, Michael E; Fortugno, Paola; Cox, Liza L; Matsuoka, Leticia S; Monetta, Rosanna; Seiler, Christoph; Pyle, Louise C; Bedoukian, Emma C; Sánchez-Soler, María José; Caluseriu, Oana; Grand, Katheryn; Tam, Allison; Aycinena, Alicia R P; Camerota, Letizia; Guo, Yiran; Sleiman, Patrick; Callewaert, Bert; Kumps, Candy; Dheedene, Annelies; Buckley, Michael; Kirk, Edwin P; Turner, Anne; Kamien, Benjamin; Patel, Chirag; Wilson, Meredith; Roscioli, Tony; Christodoulou, John; Cox, Timothy C; Zackai, Elaine H; Brancati, Francesco; Hakonarson, Hakon; Bhoj, Elizabeth J.
Afiliação
  • Li D; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. lid2@email.chop.edu.
  • March ME; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Fortugno P; Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
  • Cox LL; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • Matsuoka LS; Departments of Oral and Craniofacial Sciences and Pediatrics, University of Missouri-Kansas City School of Dentistry, Kansas City, MO, 64108, USA.
  • Monetta R; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Seiler C; Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
  • Pyle LC; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • Bedoukian EC; Zebrafish Core Facility, The Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, USA.
  • Sánchez-Soler MJ; Individualized Medical Genetics Center, Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Caluseriu O; Individualized Medical Genetics Center, Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Grand K; Sección de Genética Médica, Servicio de Pediatría, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, España.
  • Tam A; Department of Medical Genetics, University of Alberta, Edmonton, AB, T6G 2H7, Canada.
  • Aycinena ARP; The Stollery Pediatric Hospital, Edmonton, AB, T6G 2H7, Canada.
  • Camerota L; Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Guo Y; Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
  • Sleiman P; Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
  • Callewaert B; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • Kumps C; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Dheedene A; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Buckley M; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Kirk EP; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Turner A; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Kamien B; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Patel C; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Wilson M; NSW Health Pathology Genomics Laboratory, Prince of Wales Hospital, Randwick, NSW, Australia.
  • Roscioli T; NSW Health Pathology Genomics Laboratory, Prince of Wales Hospital, Randwick, NSW, Australia.
  • Christodoulou J; Centre for Clinical Genetics, Sydney Children's Hospital, Randwick, NSW, Australia.
  • Cox TC; Centre for Clinical Genetics, Sydney Children's Hospital, Randwick, NSW, Australia.
  • Zackai EH; Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia.
  • Brancati F; Genetic Health Queensland, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
  • Hakonarson H; Department of Clinical Genetics, Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Bhoj EJ; NSW Health Pathology Genomics Laboratory, Prince of Wales Hospital, Randwick, NSW, Australia.
Hum Genet ; 140(7): 1061-1076, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33811546
Teebi hypertelorism syndrome (THS; OMIM 145420) is a rare craniofacial disorder characterized by hypertelorism, prominent forehead, short nose with broad or depressed nasal root. Some cases of THS have been attributed to SPECC1L variants. Homozygous variants in CDH11 truncating the transmembrane and intracellular domains have been implicated in Elsahy-Waters syndrome (EWS; OMIM 211380) with hypertelorism. We report THS due to CDH11 heterozygous missense variants on 19 subjects from 9 families. All affected residues in the extracellular region of Cadherin-11 (CHD11) are highly conserved across vertebrate species and classical cadherins. Six of the variants that cluster around the EC2-EC3 and EC3-EC4 linker regions are predicted to affect Ca2+ binding that is required for cadherin stability. Two of the additional variants [c.164G > C, p.(Trp55Ser) and c.418G > A, p.(Glu140Lys)] are also notable as they are predicted to directly affect trans-homodimer formation. Immunohistochemical study demonstrates that CDH11 is strongly expressed in human facial mesenchyme. Using multiple functional assays, we show that five variants from the EC1, EC2-EC3 linker, and EC3 regions significantly reduced the cell-substrate trans adhesion activity and one variant from EC3-EC4 linker results in changes in cell morphology, focal adhesion, and migration, suggesting dominant negative effect. Characteristic features in this cohort included depressed nasal root, cardiac and umbilical defects. These features distinguished this phenotype from that seen in SPECC1L-related hypertelorism syndrome and CDH11-related EWS. Our results demonstrate heterozygous variants in CDH11, which decrease cell-cell adhesion and increase cell migratory behavior, cause a form of THS, as termed CDH11-related THS.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variação Genética / Anormalidades Múltiplas / Deformidades Congênitas do Pé / Deformidades Congênitas da Mão / Caderinas / Adesão Celular / Anormalidades Craniofaciais / Hipertelorismo Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variação Genética / Anormalidades Múltiplas / Deformidades Congênitas do Pé / Deformidades Congênitas da Mão / Caderinas / Adesão Celular / Anormalidades Craniofaciais / Hipertelorismo Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article